__timestamp | Phase III Trials Count |
---|---|
Friday, January 1, 2021 | 192 |
Monday, February 1, 2021 | 166 |
Monday, March 1, 2021 | 213 |
Thursday, April 1, 2021 | 203 |
Saturday, May 1, 2021 | 163 |
Tuesday, June 1, 2021 | 218 |
Thursday, July 1, 2021 | 166 |
Sunday, August 1, 2021 | 167 |
Wednesday, September 1, 2021 | 196 |
Friday, October 1, 2021 | 181 |
Monday, November 1, 2021 | 175 |
Wednesday, December 1, 2021 | 188 |
Saturday, January 1, 2022 | 177 |
Tuesday, February 1, 2022 | 149 |
Tuesday, March 1, 2022 | 183 |
Friday, April 1, 2022 | 161 |
Sunday, May 1, 2022 | 149 |
Wednesday, June 1, 2022 | 182 |
Friday, July 1, 2022 | 137 |
Monday, August 1, 2022 | 162 |
Thursday, September 1, 2022 | 154 |
Saturday, October 1, 2022 | 145 |
Tuesday, November 1, 2022 | 159 |
Thursday, December 1, 2022 | 163 |
Sunday, January 1, 2023 | 180 |
Wednesday, February 1, 2023 | 140 |
Wednesday, March 1, 2023 | 188 |
Saturday, April 1, 2023 | 144 |
Monday, May 1, 2023 | 149 |
Thursday, June 1, 2023 | 148 |
Saturday, July 1, 2023 | 142 |
Tuesday, August 1, 2023 | 158 |
Friday, September 1, 2023 | 135 |
Sunday, October 1, 2023 | 151 |
Wednesday, November 1, 2023 | 180 |
Friday, December 1, 2023 | 185 |
In pursuit of knowledge
In the past three years, the number of Phase III clinical trials initiated has shown a fluctuating trend. Starting strong in January 2021 with 192 trials, the count dipped to 137 in July 2022 before picking up again. The peak of 218 trials was reached in June 2021. Despite some variability, the overall trend seems to be stable, with an average of 168 trials per month. However, it's important to note that there are missing values in the dataset, which could potentially impact the accuracy of the trend analysis. As the field of clinical trials continues to evolve, these insights provide valuable information for researchers and stakeholders.
Number of Trials Conducted by AstraZeneca in China Post Covid
AstraZeneca COVID-19 Trials in China Over the Years
Breakdown of Trials by Type or Category for 2023 and 2024
Number of Trials with Device Based Interventions Started Since Jan 2024
Number of Phase III Trials in Atopic Dermatitis by Start Year
AstraZeneca Clinical Trials in China Post-COVID
Total trials in 2024
Total trials by start year
Number of Oncology Trials Initiated Since January 2024
Number of Oncology Trials Initiated Since January 2024
Number of Trials Conducted by AstraZeneca in China Post-COVID
AstraZeneca Clinical Trials in China Post-COVID